enprofylline has been researched along with Apnea in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Apnea: A transient absence of spontaneous respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " caused fetal apnea that was reduced from 143 +/- 45." | 3.68 | Influence of prolonged adenosine receptor blockade on fetal sleep and breathing patterns. ( Avital, A; Chernick, V; Jansen, AH; Sitar, DS, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avital, A | 1 |
| Jansen, AH | 1 |
| Sitar, DS | 1 |
| Chernick, V | 1 |
1 other study available for enprofylline and Apnea
| Article | Year |
|---|---|
Influence of prolonged adenosine receptor blockade on fetal sleep and breathing patterns.
Topics: Animals; Apnea; Female; Fetus; Infusions, Intravenous; Phenylisopropyladenosine; Pregnancy; Purinerg | 1993 |